Erenumab For Treatment of Hemicrania Continua

This research is being conducting to learn if the study drug erenumab is successful in treating hemicrania continua. The study is also evaluating the safety and tolerability of erenumab in individuals...

Lead sponsor: Mayo Clinic•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

The Will Erwin Headache Research Center - Cluster Headache Study

NCT02910323 · Cluster Headache, Cluster Headaches and Other Trigeminal Autonomic Cephalgias, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 17, 2023Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment2

Start dateAug 2021

Last updatedFeb 17, 2023

Condition

Hemicrania Continua

Locations shown

Mayo Clinic in Arizona

Scottsdale, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 17, 2023Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions